Disease/Infection News

RSS

Common sugar molecule promising target for development of broad-spectrum vaccine

Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.

28 May 2013

Molecular switch protects salmonella from harm during infection

For the first time, researchers have found a particular kind of molecular switch in the food poisoning bacteria Salmonella Typhimurium under infection-like conditions. This switch, using a process called S-thiolation, appears to be used by the bacteria to respond to changes in the environment during infection and might protect it from harm, researchers report this week online in the Proceedings of the National Academy of Sciences Early Edition.

28 May 2013

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

BioAlliance Pharma SA, a Company dedicated to the development of orphan oncology products and supportive care products, has presented the results of the pharmacokinetic and pharmacodynamic study on Sitavig at the 10th EADV spring symposium (European Academy of Dermatology and Venereology) in Cracow (Poland) on May 24, 2013.

28 May 2013

VINARES project aims to strengthen evidence-based control of antibiotic use in Vietnam

The increasingly widespread resistance to antibiotics is a global threat. One of the most vulnerable countries is Vietnam, with 90 million inhabitants. In an attempt to change this development, the VINARES project was started in the autumn of 2012 led by researchers from Sweden, UK and Vietnam.

27 May 2013

Discovery highlights new method to make HIV vaccine that targets the virus

A new discovery at Oregon Health & Science University highlights an ingenious method to ensure the body effectively reacts when infected with the highly evasive HIV virus that causes AIDS.

26 May 2013

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its proprietary vaccines, its Haidian district bulk production plants, and its Changping filing and packaging facility.

24 May 2013

New, improved drugs can boost body's natural flu killer system

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the body's natural flu killer system.

24 May 2013

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

24 May 2013

Novel multiplex immunoassay approach to capture HIV antibodies

Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies and can measure even small amounts of multiple antibodies at one time.

24 May 2013

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

Major news outlets in recent days have reported that U.S. Department of Health and Human Services Secretary Kathleen Sebelius is raising money from the private sector -- including from health care executives -- for use by a private entity that is helping to implement ObamaCare. ... Is Ms. Sebelius raising funds for a private entity and then coordinating with that entity to do something Congress has refused to authorize, or for which it has refused to appropriate funds?

24 May 2013

New campaign aims to increase awareness of HIPAA rights, benefits among HIV-positive Black MSM

The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign.

24 May 2013

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

24 May 2013

Neisseria meningitidis causes life threatening meningitis, meningococcal sepsis in humans

"Neisseria meningitidis is an important human pathogen that can cause rapidly progressing, life threatening meningitis and meningococcal sepsis in humans," Professor Jennings said.

24 May 2013

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

The Critical Care Societies Collaborative, in partnership with the U.S. Department of Health and Human Services, announces recipients in the 2013 National Awards Program to Recognize Achievements in Eliminating Health Care-Associated Infections.

24 May 2013

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new class of compounds capable of curbing the bacteria that cause staph infections.

24 May 2013

Hospitals earn nearly nine times more for treating patients who develop CLABSIs, study reports

Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units.

23 May 2013

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Today, at the World Health Assembly, top health officials from New Zealand, South Africa, Australia, Fiji and Rwanda met to discuss the vital need for countries to integrate rheumatic fever and rheumatic heart disease prevention and control into national action plans.

23 May 2013

Disease/Infection News

Common sugar molecule promising target for development of broad-spectrum vaccine

Molecular switch protects salmonella from harm during infection

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

VINARES project aims to strengthen evidence-based control of antibiotic use in Vietnam

Discovery highlights new method to make HIV vaccine that targets the virus

Sinovac Beijing receives GMP certificate for its proprietary vaccines

New, improved drugs can boost body's natural flu killer system

Findings highlight importance of IL-21 in the development of antiviral vaccines

Novel multiplex immunoassay approach to capture HIV antibodies

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

New campaign aims to increase awareness of HIPAA rights, benefits among HIV-positive Black MSM

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Neisseria meningitidis causes life threatening meningitis, meningococcal sepsis in humans

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

Hospitals earn nearly nine times more for treating patients who develop CLABSIs, study reports

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

AASLD members at forefront to raise awareness of hepatitis B and C

Scientists make important step forward in the quest to develop universal influenza vaccine

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News